Skip to main content
Log in

The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

We have studied the effect of food on the interaction of ofloxacin with sucralfate. Six healthy men took a single oral dose of ofloxacin (200 mg) on 4 occasions: alone after overnight fasting or after breakfast (non-fasting), and with sucralfate fasting or non-fasting.

There were no significant differences in the plasma concentration-time profiles of ofloxacin after ofloxacin alone between fasting and non-fasting conditions. On the other hand, the peak plasma concentration and AUC of ofloxacin after co-administration with sucralfate while fasting fell by 70 and 61 % compared with ofloxacin alone; the changes non-fasting were 39 and 31 % respectively. The interaction of ofloxacin with sucralfate was markedly reduced by food, but still could not be disregarded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Höffken G, Lode H, Wiley R, Glatzel TD, Sievers D, Olschewski T, Borner K, Koeppe T (1988) Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake. Rev Infect Dis 10 [Suppl 1]: S138-S139

    Google Scholar 

  2. Shiba K, Saito A, Miyahara T, Tachizawa H, Fujimoto T (1988) Effect of aluminum hydroxide, an antacid, on the pharmacokinetics of new quinolones in humans. Xenobiot Metab Disp 3: 717–722

    Google Scholar 

  3. Shishido H, Matsumoto K, Nugatake T, Tabuchi S (1988) Cross-over pharmacokinetics of NY-198 and ofloxacin in healthy volunteers and gastrectomized patients. Chemotherapy (Tokyo) 36 [Suppl 2]: 256–264

    Google Scholar 

  4. Flor S, Guay DRP, Opsahl JA, Tack K, Matzke GR (1990) Effect of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrob Agents Chemother 34: 2436–2438

    Google Scholar 

  5. Kawakami J, Sawada Y, Kihara E, Nakamura K, Yamada Y, Sakurai K, Seino T, Uchino K, Iga T (1992) Time-dependent inhibition of new quinolones absorption by antacids/anti-ulcer drugs containing metal cations and design for taking medicines. Jpn J Hosp Pharm 18: 1–21

    Google Scholar 

  6. Shiba K, Sakai O, Shimada J, Okezaki O, Aoki H, Hakusui H (1992) Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans. Antimicrob Agents Chemother 36: 2270–2274

    Google Scholar 

  7. Brouwers JR, Kam HJ van der, Sijtsma J, Koks CH (1989) Important drug interaction of oral ciprofloxacin with sucralfate and magnesium citrate solution. Pharm Weekbl Sci 11 [Suppl E]: 13

    Google Scholar 

  8. Nix DE, Wilton JH, Schentag JJ, Parpia SH, Norman A, Goldstein HR (1989) Inhibition of norfloxacin absorption by antacids and sucralfate. Rev Infect Dis 11 [Suppl 5]: S1096

  9. Katagiri Y, Naora K, Ichikawa N, Hayashibara M, Iwamoto K (1988) Simultaneous determination of ofloxacin, fenbufen and felbinac in rat plasma by high-performance liquid choromatography. J Chromatogr 431: 135–142

    Google Scholar 

  10. Gibaldi M, Perrier D (1975) Pharmacokinetics. Drugs and the pharmaceutical sciences, vol.1. Marcel Dekker New York

    Google Scholar 

  11. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobio-Dyn 4: 879–885

    Google Scholar 

  12. Welling PG (1984) Interactions affecting drug absorption. Clin Pharmacokinet 9: 404–434

    Google Scholar 

  13. Ichihara N, Tachizawa H, Tsumura M, Une T, Sato K (1984) Phase I study on DL-8280. Chemotherapy (Tokyo) 32 [Suppl 1]: 118–149

    Google Scholar 

  14. Nakano M, Yamamoto M, Arita T (1978) Interactions of aluminum, magnesium, and calcium ions with nalidixic acid. Chem Pharm Bull 26: 1505–1510

    Google Scholar 

  15. Issopoulos PB (1989) Spectrophotometric determination of trace amounts of iron (III) with norfloxacin as complexing reagent. Analyst 114: 627–630

    Google Scholar 

  16. Kara M, Hasinoff BB, McKay DW, Campbell NRC (1991) Clinical and chemical interactions between iron preparations and ciprofloxacin. Br J Clin Pharmacol 31: 257–261

    Google Scholar 

  17. Okabayashi Y, Hayashi F, Terui Y, Kitagawa T (1992) Studies on the interaction of pyridone carboxylic acids with metals. Chem Pharm Bull 40: 693–696

    Google Scholar 

  18. Parrish RH, Waller B, Gondalia, BG (1992) Sucralfate-warfarin interaction. Ann Pharmacother 26: 1015

    Google Scholar 

  19. Lebsack ME, Nix D, Ryerson B, Toothaker RD, Welage L, Norman AM, Schentag JJ, Sedman AJ (1992) Effect of gastric acidity on enoxacin absorption. Clin Pharmacol Ther 52: 252–256

    Google Scholar 

  20. Kobayashi H, Shimura M (1985) Phase I study with BAY o 9867 (ciprofloxacin). Chemotherapy (Tokyo) 33 [Suppl 7]: 140–170

    Google Scholar 

  21. Kawai M, Nakanishi M, Maekawa N (1984) Phase I study of AT-2266. Chemotherapy (Tokyo) 32 [Suppl 3]: 334–358

    Google Scholar 

  22. Nakashima M, Uematsu T, Takiguchi Y, Mizuno A, Kubo S, Takahara Y, Okezaki E, Nagata O (1988a) Phase I study on NY-198. Chemotherapy (Tokyo) 36 [Suppl 2]: 201–239

    Google Scholar 

  23. Abiko T, Ishihama A, Ogawa N, Uchida H, Murayama S, Hirai K, Oomori Y, Abe Y, Irikura T (1981) Phase I study on AM-715. Chemotherapy (Tokyo) 29 [Suppl 4]: 136–145

    Google Scholar 

  24. Nakashima M, Uematsu T, Kanemaru M (1988b) Phase I study of T-3262, a new pyridone-carboxylic acid derivative. Chemotherapy (Tokyo) 36 [Suppl 9]: 158–180

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawakami, J., Kotaki, H., Seino, T. et al. The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers. Eur J Clin Pharmacol 47, 67–69 (1994). https://doi.org/10.1007/BF00193481

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00193481

Key words

Navigation